| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/08/2002 | EP1172099A9 Method for transferring one or more active ingredients between different phase carriers |
| 05/08/2002 | EP0885038A4 Methods and apparatus for particle precipitation and coating using near-critical and supercritical antisolvents |
| 05/08/2002 | EP0839052B1 Use of hyaluronic acid and a nsaid for the manufacture of a medicament for the treatment of mucosal diseases |
| 05/08/2002 | EP0773780B1 Controlled release aqueous emulsion |
| 05/08/2002 | EP0726766B1 Novel pharmaceutical composition containing the ace inhibitor ramipril and a dihydropyridine compound |
| 05/08/2002 | EP0722721B1 Food-like drug |
| 05/08/2002 | EP0653935B1 Pelletised pharmaceutical composition |
| 05/08/2002 | EP0620828B1 Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
| 05/08/2002 | DE10152369A1 Stable, propellant-free inhalable liquid medicament for treating asthma or chronic obstructive pulmonary disease, containing tiotropium salt and antiallergic agent, antihistamine, steroid or leukotriene antagonist |
| 05/08/2002 | DE10055701A1 Organ-, cancer- or leukemia-specific liposomes, useful for targeted drug delivery, prepared using glycolipid component with a terminal oligosaccharide portion identical with the haptens of target body cells |
| 05/08/2002 | DE10053866A1 Biocompatible liquid formulation, containing a mixture of biopolymers, useful as a lubricant in human and veterinary medicine |
| 05/08/2002 | DE10053384A1 Pharmazeutische Zubereitung aus Mariendistel und Terpenen Pharmaceutical composition of milk thistle and terpenes |
| 05/08/2002 | DE10053383A1 Verwendung von Terpenen als Enhancer der transmucosalen Resorption und Terpene enthaltende pharmazeutische Zubereitungen Use containing terpenes as an enhancer of transmucosal absorption and terpenes pharmaceutical preparations |
| 05/08/2002 | DE10053267A1 Neuartiges Verfahren zur Herstellung von mikrosphärischen Kristalliten aus linearen Polysacchariden, entsprechende mikrosphärische Kristallite und deren Verwendung Novel method for producing microspherical crystallites of linear polysaccharides, corresponding microspherical crystallites and their use |
| 05/08/2002 | DE10051792A1 System for providing enjoyment similar to enjoyment obtained by smoking comprises cigarette-sized inhalation device, portable filler unit and stationary filler unit for filling portable filler units |
| 05/08/2002 | CN2489775Y Adhesive bandage with nm silver particle for scald |
| 05/08/2002 | CN2489774Y Adhesive bandage with nm silver fibric layer |
| 05/08/2002 | CN1348483A Stable, aqueous dispersions and stable, water-dispersible dry powders of xanthophylls, and production and use of the same |
| 05/08/2002 | CN1348464A Compositions and methods using lactadherin or variants thereof |
| 05/08/2002 | CN1348453A Derivatives of pyrimido [6.1-a] isoquinolin-4-one |
| 05/08/2002 | CN1348386A Prucalopride oral solution |
| 05/08/2002 | CN1348384A An oral formulation for ileum administering comprising an inhibitor compound of the ileal bile acid transport |
| 05/08/2002 | CN1348383A Prolonged release microsphere encapsulating luteinizing hormone-releasing hormone analogues and method for preparing the same |
| 05/08/2002 | CN1348380A Herbal composition and medicament against diabetes mellitus type II manufactured thereof |
| 05/08/2002 | CN1348377A Method for the treatment of severe chronic bronchitis (bronchiectasis) with an aerosolized antibiotic |
| 05/08/2002 | CN1348369A Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent |
| 05/08/2002 | CN1348367A Percutaneous absorption preparations containing oxybutynin |
| 05/08/2002 | CN1348366A Transdermal therapeutic system with a highly effective neuroleptic agent |
| 05/08/2002 | CN1348365A Chewing gum with dental benefits including calcium in a food grade acid |
| 05/08/2002 | CN1348364A Chewable soft capsules having improved administration properties and process for producing the same |
| 05/08/2002 | CN1348362A Magnetically responsive composition |
| 05/08/2002 | CN1348361A Method for preparing coated drug particles and pharmaceutical formulations thereof |
| 05/08/2002 | CN1348360A Preparation of aqueous clear solution dosage forms with bile acids |
| 05/08/2002 | CN1348359A Composition for medicated chewing gums process for manufacturing the same and tablets so obtained |
| 05/08/2002 | CN1348358A Utilization of an extract of a plant of the cecropia genus |
| 05/08/2002 | CN1347732A Supercritical extraction process of producing cordyceps oil |
| 05/08/2002 | CN1347713A Anorexia treating oral liquid |
| 05/08/2002 | CN1347712A Chinese herb medicine composition for curing chronic colitis, gastritis and gastric ulcer radically |
| 05/08/2002 | CN1347707A Externally applied bone Bi-syndrome treating plaster and its prepn |
| 05/08/2002 | CN1347704A Family handed traditional Chinese medicine recipe of osteomyelitis treatment |
| 05/08/2002 | CN1347694A Medicine prepn containing matrine or epimatrine and its application in analgesic medicines |
| 05/08/2002 | CN1347692A Ring medicine tablet |
| 05/08/2002 | CN1084200C Anticancer pill and its preparing process |
| 05/08/2002 | CN1084196C Burn ointment |
| 05/08/2002 | CN1084194C Process for preparing ultramicro infant medicine |
| 05/08/2002 | CN1084188C Preparation of ciprofloxacin pharmaceutical formulation composition |
| 05/08/2002 | CN1084186C Liposome composition containing selegilin |
| 05/08/2002 | CN1084185C Liquid spray for treating oral and throat disease |
| 05/08/2002 | CN1084184C Substrate of medical health-care plaster for external use and its preparing method |
| 05/07/2002 | US6384259 Heat resistant, sterile dosage suitable for reconstitution with a vehicle into an injectible, particle-free product for parenteral administration |
| 05/07/2002 | US6384252 Fatty acids or derivatives; mammalian mammary glands secretion; stress, anxiety and aggression reduction |
| 05/07/2002 | US6384090 Preparation of active ingredient dispersions and apparatus therefor |
| 05/07/2002 | US6384086 Administering to host effective amount of storage stable ethene for improving metabolic function |
| 05/07/2002 | US6384084 Histochrome and its therapeutic use in ophthalmology |
| 05/07/2002 | US6384064 Human immunodeficiency syndrone, hepatitis virus |
| 05/07/2002 | US6384062 Pharmaceutical composition |
| 05/07/2002 | US6384059 Crystalline form of omeprazole |
| 05/07/2002 | US6384020 Rapid immediate release oral dosage form |
| 05/07/2002 | US6383814 Cationic amphiphiles for intracellular delivery of therapeutic molecules |
| 05/07/2002 | US6383788 Minimizing thermally induced aggregation of DNase in solution with calcium |
| 05/07/2002 | US6383767 Luminescent in vivo glucose measurement |
| 05/07/2002 | US6383528 Antithrombotic preparation to suppress neutropenia, agranulocytosis, ischemia, and other side effects from the use of ticlopidine alone; |
| 05/07/2002 | US6383520 Fine powder of L-α-aminoadipic acid derivative, oral solid preparations containing the same, and method for treatment of bulk powders |
| 05/07/2002 | US6383519 Inorganic shaped bodies and methods for their production and use |
| 05/07/2002 | US6383518 Phosphate-binding polymer preparations |
| 05/07/2002 | US6383517 Process for preparing solid formulations of lipid-regulating agents with enhanced dissolution and absorption |
| 05/07/2002 | US6383516 Sustained-release microgranules containing diltiazem as active principle |
| 05/07/2002 | US6383515 Gelcap |
| 05/07/2002 | US6383514 Hypocholesterolemic composition comprising a phytostanol ester and a tocopherol |
| 05/07/2002 | US6383513 Compositions comprising cannabinoids |
| 05/07/2002 | US6383512 For delivering to cell a composition comprising local anesthetic and nucleic acid molecules that comprise a nucleotide sequence that encodes an antisense oligonucleotide, a ribozyme, and a triplex forming nucleic acid |
| 05/07/2002 | US6383511 Local prevention or amelioration of pain from surgically closed wounds |
| 05/07/2002 | US6383510 Suppository form comprising an acid-labile active compound |
| 05/07/2002 | US6383509 Continuous in vivo release of a neurotoxin over a treatment period extending from one month to five years; neurotoxin, especially botulinum toxin or clostridial neurotoxin, within a polymeric matrix |
| 05/07/2002 | US6383502 Non-stinging coating composition |
| 05/07/2002 | US6383500 Particles comprising amphiphilic copolymers, having a crosslinked shell domain and an interior core domain, useful for pharmaceutical and other applications |
| 05/07/2002 | US6383499 Topical medicament for the treatment of psoriasis |
| 05/07/2002 | US6383478 Polymeric encapsulation system promoting angiogenesis |
| 05/07/2002 | US6383471 Drug delivery |
| 05/07/2002 | CA2325257A1 Emulsified delivery system for hydrophobic and hydrophilic pharmaceutical agents |
| 05/07/2002 | CA2214884C Poly(hydroxy acid)/polymer conjugates for skin applications |
| 05/07/2002 | CA2205305C Stable budesonide solutions, method of preparing them and use of these solutions as enema preparations and pharmaceutical foams |
| 05/07/2002 | CA2175842C Transesterified corn oil products |
| 05/07/2002 | CA2085871C A controlled release drug dispersion delivery device |
| 05/02/2002 | WO2002034885A1 Sericin-containing material, process for producing the same and method of using the same |
| 05/02/2002 | WO2002034816A1 Method for producing microspherical crystallites from linear polysaccharides, corresponding microspherical crystallites and the use thereof |
| 05/02/2002 | WO2002034306A1 Surface modification of islet membranes by polymeric grafting methods |
| 05/02/2002 | WO2002034304A1 Self-adhesive hydratable matrix for topical therapeutic use |
| 05/02/2002 | WO2002034303A1 Methods of treating vascular diseases characterized by nitric oxide insufficiency |
| 05/02/2002 | WO2002034299A1 Inorganic low density radionuclide coated particles |
| 05/02/2002 | WO2002034294A1 Use of terpenes as enhancers of transmucosal resorption, and pharmaceutical preparations containing terpenes |
| 05/02/2002 | WO2002034293A2 Use of citric acid as antimicrobial agent or enhancer or as anticancer agent |
| 05/02/2002 | WO2002034279A1 Oral preparation containing seaweed for reduction of plaque and calculus |
| 05/02/2002 | WO2002034275A1 Pharmaceutical preparation comprised of milk-thistle and terpenes |
| 05/02/2002 | WO2002034271A1 New composition and method for the treatment of dysglucaemia |
| 05/02/2002 | WO2002034270A1 Treatment of respiratory distress syndrome with powder surfactant composition |
| 05/02/2002 | WO2002034267A1 Combination of a transdermal therapeutic system and an oral and/or parenteral preparation containing dopamine agonists for the treatment of dopaminergic disease states |
| 05/02/2002 | WO2002034263A1 Preventives/remedies for portal hypertension |
| 05/02/2002 | WO2002034258A1 Use of hydroxyeicosatetraenoic acid derivatives in intraocular surgery |
| 05/02/2002 | WO2002034256A1 Process for producing granular drug preparation containing branched amino acids |